344 related articles for article (PubMed ID: 20714774)
1. Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings.
Abd-Elkareem MI; Al Tamimy HM; Khamis OA; Abdellatif SS; Hussein MR
Clin Exp Nephrol; 2010 Dec; 14(6):548-57. PubMed ID: 20714774
[TBL] [Abstract][Full Text] [Related]
2. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
[TBL] [Abstract][Full Text] [Related]
3. [Urinary soluble intercellular adhesion molecule-1 and vascular cellular adhesion molecule-1: potential biomarkers of active lupus nephritis].
Wu C; Yang M; Zhou Z; Feng X; Zhong X; Cui S; Wu L; Cao W
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1272-6, 1282. PubMed ID: 26403737
[TBL] [Abstract][Full Text] [Related]
4. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
[TBL] [Abstract][Full Text] [Related]
5. Urine sVCAM-1 and sICAM-1 levels are elevated in lupus nephritis.
Howe HS; Kong KO; Thong BY; Law WG; Chia FL; Lian TY; Lau TC; Chng HH; Leung BP
Int J Rheum Dis; 2012 Feb; 15(1):13-6. PubMed ID: 22324942
[TBL] [Abstract][Full Text] [Related]
6. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
Front Immunol; 2022; 13():885307. PubMed ID: 35720325
[TBL] [Abstract][Full Text] [Related]
7. Urine angiostatin and VCAM-1 surpass conventional metrics in predicting elevated renal pathology activity indices in lupus nephritis.
Soliman S; Mohamed FA; Ismail FM; Stanley S; Saxena R; Mohan C
Int J Rheum Dis; 2017 Nov; 20(11):1714-1727. PubMed ID: 29076253
[TBL] [Abstract][Full Text] [Related]
8. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
[TBL] [Abstract][Full Text] [Related]
9. Relationship between lupus nephritis activity and the serum level of soluble VCAM-1.
Ikeda Y; Fujimoto T; Ameno M; Shiiki H; Dohi K
Lupus; 1998; 7(5):347-54. PubMed ID: 9696139
[TBL] [Abstract][Full Text] [Related]
10. Urinary sediment ICAM-1 level in lupus nephritis.
Guan J; Wang G; Tam LS; Kwan BC; Li EK; Chow KM; Li PK; Szeto CC
Lupus; 2012 Oct; 21(11):1190-5. PubMed ID: 22685016
[TBL] [Abstract][Full Text] [Related]
11. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between sera levels of sICAM-1 and sVCAM-1 and severity of kidney lesions in patients with lupus nephritis].
Ilić T; Mitić I; Durdević-Mirković T; Vucković B; Milić B; Popović M
Med Pregl; 2007; 60 Suppl 2():128-32. PubMed ID: 18928178
[TBL] [Abstract][Full Text] [Related]
13. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.
Parodis I; Gokaraju S; Zickert A; Vanarsa K; Zhang T; Habazi D; Botto J; Serdoura Alves C; Giannopoulos P; Larsson A; Svenungsson E; Gunnarsson I; Mohan C
Rheumatology (Oxford); 2020 Sep; 59(9):2237-2249. PubMed ID: 31722419
[TBL] [Abstract][Full Text] [Related]
14. Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage.
Molad Y; Miroshnik E; Sulkes J; Pitlik S; Weinberger A; Monselise Y
Clin Exp Rheumatol; 2002; 20(3):403-6. PubMed ID: 12102480
[TBL] [Abstract][Full Text] [Related]
15. Radix Paeoniae Rubra Ameliorates Lupus Nephritis in Lupus-Like Symptoms of Mrl Mice by Reducing Intercellular Cell Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and Platelet Endothelial Cell Adhesion Molecule-1 Expression.
Wang W; Cao L; Wang X; Fan Y
Comb Chem High Throughput Screen; 2020; 23(7):675-683. PubMed ID: 32416674
[TBL] [Abstract][Full Text] [Related]
16. Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis.
Singh S; Wu T; Xie C; Vanarsa K; Han J; Mahajan T; Oei HB; Ahn C; Zhou XJ; Putterman C; Saxena R; Mohan C
Arthritis Res Ther; 2012 Jul; 14(4):R164. PubMed ID: 22788914
[TBL] [Abstract][Full Text] [Related]
17. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
[TBL] [Abstract][Full Text] [Related]
18. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited.
Belmont HM; Buyon J; Giorno R; Abramson S
Arthritis Rheum; 1994 Mar; 37(3):376-83. PubMed ID: 7510492
[TBL] [Abstract][Full Text] [Related]
20. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M
Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
